Henrik Schröder
Geboren:
1971
Hat mitgewirkt an:
-
Correction to: Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-Month outcomes in the full cohort of BIOLUX P-III global registry
-
Paclitaxel-coated balloon for the treatment of infrainguinal disease: 12-month outcomes in the all-comers cohort of BIOLUX p-III global registry
-
Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-month outcomes in the full cohort of BIOLUX P-III Global Registry
-
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions